Dyb venetrombose i overekstremiteterne med fokus på Paget-Schrötters syndrom

Jærn Dalsgaard Nielsen; Thomas Steffen Hermann

doi:10.61409/V09240609

Dyb venetrombose i overekstremiteterne med fokus på Paget-Schrötters syndrom

Translated title of the contribution: Deep vein thrombosis in the upper extremities focusing on Paget-Schrötter syndrome

Jærn Dalsgaard Nielsen^*, Thomas Steffen Hermann

^*Corresponding author for this work

Department of Cardiology

Abstract

Among the three main forms of upper extremity deep vein thrombosis (UE-DVT), catheter-related UE-DVT has the highest incidence, cancer-associated UE-DVT the highest mortality, and primary UE-DVT (Paget-Schrötter syndrome) the most varied treatment proposals. This review finds that nticoagulant treatment (AC) for 3-6 months leads to symptom freedom or mild postthrombotic syndrome in most patients. Still, several studies show better results after surgical treatment if performed less-than 6 weeks after symptom onset. A randomized study of AC alone versus AC + surgery less-than 6 weeks in patients with persistent symptoms is warranted.

Translated title of the contribution	Deep vein thrombosis in the upper extremities focusing on Paget-Schrötter syndrome
Original language	Danish
Article number	V09240609
Journal	Ugeskrift for Laeger
Volume	187
Issue number	11
ISSN	0041-5782
DOIs	https://doi.org/10.61409/V09240609
Publication status	Published - 10 Mar 2025

Access to Document

10.61409/V09240609Licence: CC BY-NC-ND

Cite this

@article{25013651df32447ebe0c627b8a60a647,

title = "Dyb venetrombose i overekstremiteterne med fokus p{\aa} Paget-Schr{\"o}tters syndrom",

abstract = "Among the three main forms of upper extremity deep vein thrombosis (UE-DVT), catheter-related UE-DVT has the highest incidence, cancer-associated UE-DVT the highest mortality, and primary UE-DVT (Paget-Schr{\"o}tter syndrome) the most varied treatment proposals. This review finds that nticoagulant treatment (AC) for 3-6 months leads to symptom freedom or mild postthrombotic syndrome in most patients. Still, several studies show better results after surgical treatment if performed less-than 6 weeks after symptom onset. A randomized study of AC alone versus AC + surgery less-than 6 weeks in patients with persistent symptoms is warranted.",

keywords = "Humans, Upper Extremity Deep Vein Thrombosis/drug therapy, Anticoagulants/therapeutic use, Postthrombotic Syndrome",

author = "Nielsen, \{J{\ae}rn Dalsgaard\} and Hermann, \{Thomas Steffen\}",

note = "Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.",

year = "2025",

month = mar,

day = "10",

doi = "10.61409/V09240609",

language = "Dansk",

volume = "187",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske L{\ae}geforening",

number = "11",

}

TY - JOUR

T1 - Dyb venetrombose i overekstremiteterne med fokus på Paget-Schrötters syndrom

AU - Nielsen, Jærn Dalsgaard

AU - Hermann, Thomas Steffen

N1 - Published under Open Access CC-BY-NC-BD 4.0. https://creativecommons.org/licenses/by-nc-nd/4.0/.

PY - 2025/3/10

Y1 - 2025/3/10

N2 - Among the three main forms of upper extremity deep vein thrombosis (UE-DVT), catheter-related UE-DVT has the highest incidence, cancer-associated UE-DVT the highest mortality, and primary UE-DVT (Paget-Schrötter syndrome) the most varied treatment proposals. This review finds that nticoagulant treatment (AC) for 3-6 months leads to symptom freedom or mild postthrombotic syndrome in most patients. Still, several studies show better results after surgical treatment if performed less-than 6 weeks after symptom onset. A randomized study of AC alone versus AC + surgery less-than 6 weeks in patients with persistent symptoms is warranted.

AB - Among the three main forms of upper extremity deep vein thrombosis (UE-DVT), catheter-related UE-DVT has the highest incidence, cancer-associated UE-DVT the highest mortality, and primary UE-DVT (Paget-Schrötter syndrome) the most varied treatment proposals. This review finds that nticoagulant treatment (AC) for 3-6 months leads to symptom freedom or mild postthrombotic syndrome in most patients. Still, several studies show better results after surgical treatment if performed less-than 6 weeks after symptom onset. A randomized study of AC alone versus AC + surgery less-than 6 weeks in patients with persistent symptoms is warranted.

KW - Humans

KW - Upper Extremity Deep Vein Thrombosis/drug therapy

KW - Anticoagulants/therapeutic use

KW - Postthrombotic Syndrome

UR - https://www.scopus.com/pages/publications/105002362050

U2 - 10.61409/V09240609

DO - 10.61409/V09240609

M3 - Review

C2 - 40152145

SN - 0041-5782

VL - 187

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 11

M1 - V09240609

ER -

Dyb venetrombose i overekstremiteterne med fokus på Paget-Schrötters syndrom

Abstract

Access to Document

Other files and links

Fingerprint

Cite this